Walgreens Boots Alliance, Inc. with ticker code (WBA) have now 13 analysts in total covering the stock. The consensus rating is pointing to ‘hold’. The range between the high target price and low target price is between $42.44 and $20.75 and has a mean target at $26.11. Given that the stocks previous close was at $21.65 and the analysts are correct then we can expect a percentage increase in value of 20.6%. It’s also worth noting that there is a 50 day moving average of $22.05 while the 200 day moving average is $29.81. The total market capitalization for the company now stands at 18.14B. The current share price for the company is: $21.00 USD
The potential market cap would be $21,879,596,525 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of -, revenue per share of $161.12 and a 1.48% return on assets.
Walgreens Boots Alliance, Inc. is an integrated healthcare, pharmacy and retailing company. The Company operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The Company’s U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in AmerisourceBergen. Its International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. Its portfolio of consumer brands include Walgreens, Boots, Duane Reade, the No7 Beauty Company, Benavides in Mexico and Ahumada in Chile. Its U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey.
